
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Interest Expense 2011-2026 | ABMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 58.7 M | 7.61 M | 30.4 M | -388 K | -349 K | 339 K | -97 K | 49 K | 326 K | 9 K | -143 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.7 M | -388 K | 8.76 M |
Quarterly Interest Expense Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 80.7 M | 84.5 M | - | -7.58 M | 6.84 M | 46.8 M | - | 7.94 M | 7.94 M | 9.76 M | 24.6 M | 23.7 M | 23.7 M | -45.8 M | 39.4 M | -20 K | -20 K | -158 K | - | -81 K | -23 K | 79 K | - | -34 K | -225 K | -191 K | - | -29 K | 111 K | 140 K | - | -10 K | -38 K | -39 K | - | 20 K | 5 K | -15 K | - | 324 K | 311 K | -13 K | - | 39 K | 24 K | -15 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 84.5 M | -45.8 M | 8.18 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 184.69 | 2.23 % | $ 13.8 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
167 K | $ 34.46 | 2.96 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.77 | 3.65 % | $ 1.73 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 292.23 | 1.41 % | $ 8.24 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.37 | 1.35 % | $ 126 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.9 | 2.18 % | $ 5.94 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 63.82 | 1.01 % | $ 94.5 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.34 | -1.71 % | $ 169 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 10.38 | 3.7 % | $ 294 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
78 K | $ 25.21 | 1.47 % | $ 213 M | ||
|
LENSAR
LNSR
|
636 K | $ 6.04 | 2.03 % | $ 72.2 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 94.94 | 2.11 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.98 | -2.46 % | $ 1.2 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.44 | 3.74 % | $ 940 M | ||
|
Myomo
MYO
|
-668 K | $ 0.79 | 8.49 % | $ 33.1 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.86 | 5.37 % | $ 419 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.88 | 4.11 % | $ 390 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 56.83 | 3.48 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 39.73 | 3.3 % | $ 1.23 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 64.99 | 0.63 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 88.63 | 1.03 % | $ 3.08 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.76 | 0.27 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 78.2 | 0.1 % | $ 45.7 B |